Have you seen the latest news and insights on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: Pravibismane Receives FDA Orphan Drug Status for Treatment of CF Lung Infections Pravibismane Receives FDA Orphan Drug Status for Treatment of CF Lung Infections Jun 01, 2020 07:00 am | Vanessa Pataia Pravibismane suspension, a new type of inhaled antimicrobial medication developed by Microbion, has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of lung infections in patients with cystic fibrosis (CF). This designation provides incentives for the development of treatments for rare diseases — conditions that affect fewer than 200,000 […] The post Pravibismane Receives FDA Orphan Drug Status for Treatment of CF Lung Infections appeared first on Cystic Fibrosis News Today. Read More Recent News COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say Let’s Unite to Ditch the Charade of ‘I’m Fine’ Mobile PERT App Helps Improve Quality of Life for Children With CF, Study Shows Real-world Use of Kalydeco for CF Highly Effective, Large-scale Analysis Shows Microbe DNA Discovery May Lead to Noninvasive Test for CF Infections